Streetbeat News

Earnings

SNOW

Recent options activity for Snowflake (NYSE:SNOW) shows a mix of bullish and bearish sentiment among investors, with a notable volume of trades focusing on a price window from $130.0 to $240.0. The company, known for its data lake, warehousing, and sharing solutions, has seen its stock price increase by 0.54% to $157.82. Analysts have set an average price target of $224.0, with specific targets ranging from $170 to $265. The next earnings report is expected in 65 days, and current RSI values suggest the stock may be oversold.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 2:46 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has seen a bullish trend in options trading, with 71% of traders showing bullish sentiment. Significant trading activity aims for a price range of $200 to $330. Recent analyst ratings vary, with an average target price of $322. The stock is currently up 1.17% at $285.47, with potential indicators of being oversold. Next earnings report is due in 64 days.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 2:46 pm

TSLA

Tesla Inc (NASDAQ:TSLA) shares are up after announcing Model Y price increases in several countries and the U.S. Despite this, Goldman Sachs analyst Mark Delaney maintained a Neutral rating on Tesla, lowering the price target from $220 to $190 due to production challenges and weakening EV demand. Tesla's recent performance has been affected by declining demand in the EV market, pricing wars, disappointing delivery numbers, and a significant sales drop in China.

Portfolio Pulse from Adam Eckert

March 18, 2024 | 2:38 pm

SHCO

Soho House & Co's stock (SHCO) is trading higher, potentially rebounding from a previous drop due to worse-than-expected Q4 financial results. This comes after Executive Chairman Ron Burkle issued a shareholder letter.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:31 pm

SOND

Sonder Holdings announced a delay in its Q4 and FY23 financial results due to accounting errors, alongside preliminary Q4 and FY23 revenue results that fell below estimates.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:25 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) announced positive results from the DUO-E Phase 3 trial of Imfinzi plus Lynparza in pMMR advanced or recurrent endometrial cancer, showing significant clinical benefits over chemotherapy alone. The combination therapy demonstrated improvements in key secondary efficacy endpoints, including duration of response and reduction in the risk of second progression or death. Additionally, AstraZeneca revealed a new pricing policy for its U.S. inhaled respiratory medicines, capping the cost at $35 per month for eligible patients starting June 1, 2024. AZN shares slightly declined by 0.24% to $66.15.

Portfolio Pulse from Vandana Singh

March 18, 2024 | 2:25 pm

SHCO

Soho House & Co's stock (SHCO) is experiencing a rebound in trading, potentially recovering from a significant drop last Friday due to disappointing Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:19 pm

LEGH

Legacy Housing's stock price declined following the announcement of disappointing Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:18 pm

LEGH

Legacy Housing (NASDAQ:LEGH) reported Q4 2023 earnings of $0.34 per share, missing the consensus estimate of $0.77 by 55.84%. Quarterly sales were $33.670M, missing the estimate of $60.648M by 44.48%, and representing a 55.43% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 2:16 pm

STNE

StoneCo Ltd. (NASDAQ:STNE) is set to release its Q4 financial results on March 18, 2024, with analysts forecasting a significant increase in earnings per share from 15 cents to 30 cents year-over-year, and revenue expected to rise from $549.66 million to $685.73 million. The company recently received a Financeira License from the Brazilian Central Bank, enhancing its credit, financing, and investment capabilities. Despite this, StoneCo shares slightly fell by 0.3% to $17.30. Analyst ratings have varied, with adjustments in price targets and changes from Buy to Neutral by notable analysts.

Portfolio Pulse from Avi Kapoor

March 18, 2024 | 2:14 pm